Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 and HADS-D in Primary Care, findings from the UPBEAT-UK Study by Haddad, M. et al.
Haddad, M., Walters, P., Phillips, R., Tsakok, J., Williams, P., Mann, A. & Tylee, A. (2013). 
Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 
and HADS-D in Primary Care, findings from the UPBEAT-UK Study. PLoS One, 8(10), e78493 . 
doi: 10.1371/journal.pone.0078493 
City Research Online
Original citation: Haddad, M., Walters, P., Phillips, R., Tsakok, J., Williams, P., Mann, A. & Tylee, 
A. (2013). Detecting depression in patients with coronary heart disease: a diagnostic evaluation of 
the PHQ-9 and HADS-D in Primary Care, findings from the UPBEAT-UK Study. PLoS One, 8(10), 
e78493 . doi: 10.1371/journal.pone.0078493 
Permanent City Research Online URL: http://openaccess.city.ac.uk/2914/
 
Copyright & reuse
City University London has developed City Research Online so that its users may access the 
research outputs of City University London's staff. Copyright © and Moral Rights for this paper are 
retained by the individual author(s) and/ or other copyright holders.  All material in City Research 
Online is checked for eligibility for copyright before being made available in the live archive. URLs 
from City Research Online may be freely distributed and linked to from other web pages. 
Versions of research
The version in City Research Online may differ from the final published version. Users are advised 
to check the Permanent City Research Online URL above for the status of the paper.
Enquiries
If you have any enquiries about any aspect of City Research Online, or if you wish to make contact 
with the author(s) of this paper, please email the team at publications@city.ac.uk.
Detecting Depression in Patients with Coronary Heart
Disease: a Diagnostic Evaluation of the PHQ-9 and HADS-
D in Primary Care, Findings From the UPBEAT-UK Study
Mark Haddad1, Paul Walters2, Rachel Phillips2, Jacqueline Tsakok2, Paul Williams2, Anthony Mann2,
André Tylee2*
1 School of Health Sciences, City University London, London, United Kingdom, 2 Health Services and Population Research Department, Institute of Psychiatry
at King’s College London, London, United Kingdom
Abstract
Objective: People with coronary heart disease (CHD) are at heightened risk of depression, and this co-occurrence of
conditions is associated with poorer outcomes including raised mortality. This study compares the diagnostic
accuracy of two depression case finding instruments in CHD patients relative to a diagnostic standard, the revised
Clinical Interview Schedule (CIS-R).
Methods: The Patient Health Questionnaire (PHQ-9), the Hospital Anxiety and Depression Scale depression
subscale (HADS-D) and the CIS-R depression module were administered to 803 patients identified from the CHD
registers of GP practices in Greater London.
Results: Of 730 recruited patients without previously identified depression, 32 (4.4%) met ICD-10 depressive
episode criteria according to the CIS-R. For the PHQ-9 and HADS-D lower cut-points than those routinely
recommended were associated with improved case identifying properties. The PHQ-9 appeared the superior
instrument using a cut-point of ≥8 (sensitivity=94%; specificity=84%). Using categorical scoring the PHQ-9 was 59%
sensitive and 95% specific. For the HADS-D using cut-point ≥5, sensitivity was 81% and specificity was 77%.
Areas under the curves (AUC) (standard error) were 0.95 (0.01) and 0.88 (0.02) for the PHQ-9 and HADS-D, and
0.91 (0.02) for PHQ-9 using the categorical algorithm. Statistically significant differences between AUCs of the
PHQ-9 and the HADS-D favoured the former. Severity ratings compared across measures indicated inconsistency
between recommended bandings: the PHQ-9 categorised a larger proportion of participants with mild and moderate
depression.
Conclusion: This is the first large-scale investigation of the accuracy of these commonly used measures within a
primary care CHD population. Our results suggest that although both scales have acceptable abilities and can be
used as case identification instruments for depression in patients with CHD, the PHQ-9 appeared diagnostically
superior. Importantly, optimal cut-off points for depression identification in this population appear to differ from
standard values, and severity ratings differ between these measures.
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Introduction
Depression is one of the commonest mental disorders, with a
12-month community prevalence of 4% to 7 % [1,2]. It is
currently the third leading cause of burden of disease burden in
the world, and the leading cause in middle- and high-income
countries [3].
The risk of depression is significantly increased among
people with chronic illnesses such as coronary heart disease
(CHD), chronic obstructive pulmonary disease (COPD),
diabetes, and asthma, with rates consistently found to be two-
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to three-times times higher than in the general population [4,5].
When depression co-occurs with a medical illness it is
associated with poorer physical, mental, and social functioning
in all age groups than either depression or physical illness
alone [6]. In the case of CHD, co-occurrence with depression
predicts a doubling of the risk of cardiac events in the years
following myocardial infarction [7], and a similar increase in
mortality [8].
Recognition of depression is important for treatment and
monitoring, but a substantial body of research has found this to
be poor in primary care and medical settings [9]. Difficulties in
case identification appear to be amplified by the presence of
concurrent medical conditions such as CHD [10,11]. In
response to this, the use of validated brief self-report scales to
improve case identification for depression has received much
attention and been advocated by clinical guidelines in the USA
[12], whilst in the UK, the Quality and Outcomes Framework
(QOF) has since 2006 provided incentives for general
practitioners’ (GPs) systematic use of a brief depression case
identification instrument in particular vulnerable groups.
Despite the relative ease of application and apparent utility of
depression screening tools, there remain important questions
about the effect of this approach for clinical outcomes in
primary care patients [13]. A key problem with depression
screening within an unselected primary care population is that
the positive predictive value derived from available instruments
is too low – primarily because of the relatively low prevalence
of undisclosed depression in this patient group. However, the
use of case-finding tools in high-risk groups is likely to yield a
lower frequency of false-positive results and hence appears a
more appropriate strategy than routine screening, and this is
the basis of recommendations for systematic case identification
among people at increased risk of depression because of past
history or specific conditions such as CHD [7,14]. The
American Heart Association, endorsed by the American
Psychiatry Association, stress that the opportunity to screen for
and treat depression in cardiac patients should not be missed,
and recommend routine screening for depression in patients
with CHD in the various settings where they receive care [7].
The UK National Institute for Health and Care Effectiveness,
whilst not recommending routine depression screening in
primary care [15], does advocate the continuing use of a two
question depression screen [16] in the case identification of
depression among people with patient with a chronic physical
health problem [14]; and, alongside further psychosocial
assessment of patients who respond positively, to consider
using a validated measure to inform and evaluate treatment.
Hence, use of depression case identifying measures (aside
from a two-item screen) in the UK is largely for purposes of
confirmation of diagnostic suspicion, indication of condition
severity, and monitoring responses to management, rather
than screening.
There remain important questions about the clinical value of
depression screening: leading commentators note that there is
a lack of evidence for this approach leading to improved
outcomes, and voice associated concerns about its cost-
effectiveness [17,18]. There may also be the potential for
harms such as incorrectly identifying (false-positive results) and
treating individuals for depression, providing treatment of
symptoms that may be likely to be self-limiting, and the
possible adverse psychological and behavioural consequences
of identifying depression among individuals previously
unconcerned about their mental health [19]. Alongside these
key issues, there are uncertainties about the most appropriate
instruments and scale cut-off points for use with CHD patients,
whether for their use (as recommended in the USA) in
screening, or for the purposes advocated in the UK of case
identification and diagnostic confirmation.
The Patient Health Questionnaire (PHQ-9) and the
depression subscale of the Hospital Anxiety and Depression
Scale (HADS-D) are commonly used to improve the
identification and management of comorbid depression in
people with medical conditions. Previous research has
examined the validity and psychometric properties of these
instruments among primary care patients [20], among patients
with comorbid chronic conditions including CHD [21], and
among recently discharged CHD patients [22], as well as those
with a longer history of CHD [23]. A systematic review [24] of
the diagnostic accuracy of these and other widely-used case
identification tools for depression among patients with long-
term medical conditions found that although most scales
performed adequately using standard cut-points, the PHQ-9
(sensitivity=84%; specificity=88%) achieved greater overall
accuracy than the HADS-D (sensitivity=75%; specificity=81%).
A systematic review focussing on the adequacy of screening
methods specifically for patients with cardiovascular disease
[25] identified inconsistencies in the performance and optimal
thresholds of these instruments between samples. Among the
reviewed studies, a large-scale community study of CHD
outpatients [23] found the standard PHQ-9 cut-point (≥10) had
only 54% sensitivity and 90% specificity, with further post hoc
analysis [26] indicating that a PHQ-9 cut-off score of ≥6 was
optimal: 83% sensitive and 76% specific. This same PHQ-9
cut-off score of ≥6 was also indicated in a smaller study
examining patients within 3 months of discharge following
cardiac events [22] (sensitivity=83%; specificity=79%).
Evaluations of the HADS-D in this patient group have similarly
indicated a lowering of cut-points for optimal accuracy:
thresholds of ≥6 (sensitivity=80%, specificity=82%) [22] or ≥4
for major depression (sensitivity=85%, specificity=75%) [27]
have been advocated.
Importantly, studies of the diagnostic accuracy of these
instruments in CHD patients have recruited samples almost
exclusively from either hospitalized patients or recently
discharged patients with recent acute coronary syndrome or
coronary revascularization; only one study of community based
cardiology outpatients approximates to a primary care sample
[26]. The lack of investigation of the characteristics and
accuracy of depression case finding tools among a primary
care CHD population is a limitation within this literature. This is
important because primary care is the setting where there is
most opportunity and potential value in identifying depression
among people with CHD.
A further problem evident in the literature is that although
there are a large number of primary studies reporting
evaluations of the characteristics of depression case
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identification tools, the overwhelming majority of these
diagnostic accuracy studies fail to exclude patients who already
have a diagnosis of or are receiving treatment for depression.
A recent systematic review [28] identified that only around 5%
of nearly 200 unique publications specifically removed
depressed patients from the sample in which the tool was
evaluated. Because screening is designed to identify those
patients who may have a condition, but are neither seeking
treatment nor have had the target condition otherwise
recognised, then including patients already identified as cases
does not represent the population among which this procedure
would be used in real practice (termed spectrum bias). Failing
to omit such patients compromises the validity of findings: the
increased prevalence and severity of depression in the sample
being examined may inflate the reported sensitivity of the index
test in relation to the reference standard, and give rise to
inaccurate and misleading estimates of the positive predictive
value and new case yield that may be derived from the use of
the test in normal clinical practice.
As well as concerns about the accuracy of previous study
findings and their generalizability to primary care CHD
populations and uncertainties about the optimal scale
thresholds for this patient group, previous studies indicate that
the PHQ-9 and HADS-D differ in the proportion of people
classified with mild, moderate, or severe depression [20,29],
and it seems likely that these inconsistencies of categorisation
may also be evident for people with CHD. Accordingly, this
study aims to determine the performance characteristics of
these two widely used depression scales in a large
representative primary care based UK sample of patients with
CHD from which those patients who already have a diagnosis
of or are receiving treatment for depression have been
excluded, and to examine the relative severity classifications
derived from these instruments.
Methods
Ethics statement
All study participants provided written informed consent and
relevant documentation was retained in patients’ medical notes
and the research records. This study including the consent
procedure received ethical approval from the Bexley and
Greenwich Research Ethics Committee (REC Reference: 07/
H0809/38).
Study Design
This study uses a cross-sectional design to compare the
psychometric characteristics of the PHQ-9 and HADS-D, with
reference to the CIS-R as a diagnostic standard. This study
forms part of a wider exploration of depression and CHD in
primary care in which these and other measures are used to
examine prevalence, incidence, course, predictors,
management, and experience of these commonly comorbid
conditions [30].
Setting
Patients were recruited from the CHD registers kept by
general practices in South London (In 2004, the Quality &
Outcomes Framework, part of the General Medical Services
contract for England, introduced and incentivised arrangements
for practices to identify their patient population with registers of
particular clinical conditions to enable effective call and recall of
patients in any disease category and in order to be able to
report on relevant indicators). All patients on the CHD registers
in 16 participating general practices were invited to participate
in the study. Practices were selected with the intention of
yielding participants with a mix of socio-economic and urban/
rural status.
Participants
Inclusion criteria.  Patients were eligible for study inclusion
if they were aged 18 years and had been placed on the
practice register of patients with coronary heart disease. The
coronary heart disease register includes all patients in
practices who have a past history of myocardial infarction,
diagnosed angina, or had coronary artery revascularisation
procedures such as coronary artery bypass grafting (CABG).
Patients are assigned to the register on the basis of disease,
investigation and intervention procedure codes within their
electronic medical record.
Exclusion criteria.  Patients were excluded if they did not
have the necessary spoken or written language skills or were
registered at the participating general practice as temporary
patients. For this diagnostic accuracy study (though not for
other studies within the UPBEAT-UK programme), patients
already recognised or treated for depression were also
excluded.
Depression Severity Measures
The depression severity measures to be assessed
comprised the HADS and PHQ-9, with accuracy compared to
the CIS-R.
The PHQ-9 is a self-rating instrument for depression
developed in the late 1990s from the Primary Care Evaluation
of Mental Disorders (PRIME-MD) [31]. It consists of nine items
designed to correspond to the Diagnostic and Statistical
Manual of Mental Disorder (DSM-IV) [32]diagnostic criteria for
major depressive disorder. Respondents rate the scale items
from 0 to 3 according to the frequency of their experience over
the previous 2-week period (not at all, several days, more than
half the days, or nearly every day). As has been noted, a cut-
off score equal or greater than 10 is most commonly used for
depression identification, and a systematic review of studies in
general practice conducted for most recent UK depression
clinical guidelines [15] indicated a sensitivity of 82% and a
specificity of 83% using this cut-point. Similar findings are
reported from studies of people with chronic physical health
problems or within general medical settings [24]. The PHQ-9
score can be used to indicate depression severity, however
studies have found discrepancies in PHQ-9 severity bandings
compared to other measures [20,29]. In addition to its use as a
self-report case identification and severity measure, the PHQ-9
also includes a scoring algorithm that applies DSM-IV disorder
Detecting Depression in Coronary Disease Patients
PLOS ONE | www.plosone.org 3 October 2013 | Volume 8 | Issue 10 | e78493
criteria to the nine items wherein major depression is
diagnosed if 5 or more of the 9 depressive symptom criteria
have been present at least “more than half the days” over the
past two weeks, and one of these symptoms is depressed
mood or anhedonia. One of the 9 symptom criteria (“thoughts
that you would be better off dead or of hurting yourself in some
way”) counts if present at all, regardless of duration. If 2, 3, or 4
depressive symptoms have been present at least “more than
half the days”, and one of the symptoms is depressed mood or
anhedonia ‘other depressive syndrome’ may be diagnosed
[33].
The HADS [34] rating scale is comprised of fourteen items,
seven of which are designed to measure anxiety (HADS-A),
and seven depression (HADS-D). Each of the items is scored
on a four-point scale from zero (not present) to three
(considerable). The item scores are summed, to provide sub-
scale scores on the HADS-D and the HADS-A which may
range between zero to 21. Studies most commonly employ a
cut-point of ≥ 8 (eight and above) for each of the constituent
subscales, as suggested by its authors, to indicate probable
caseness. Studies of common mental disorders in primary care
settings have utilised this cut-off score for caseness [35] and a
systematic review reported that this threshold provides an
optimal balance between sensitivity and specificity for both
HADS-A and HADS-D [36]. The HADS-D has been used as for
depression case-finding in a diverse and broad range of clinical
groups including those with coronary heart disease [37],
chronic fatigue, cancer, musculo-skeletal disease, as well as
general population samples and primary care samples [38].
The CIS-R is a short lay interviewer administered structured
interview schedule covering non-psychotic symptoms
particularly those associated with depression and anxiety in the
past month and past week [39]. It elicits responses to 14 areas
of symptoms including depression, anxiety, panic, sleep and
fatigue. Ratings can be summed to generate a total score, as
well used to provide diagnostic categories according to ICD-10.
Algorithms based on the type and number of reported
symptoms enable catgorisation of depression episode severity
as mild, moderate, or severe. The CIS-R is widely used,
especially in the UK where it has been the main identification
measure for common mental disorders in the national
Psychiatric Morbidity Surveys carried out in 1993, 2000 and
2007. It has been found to have moderate validity with respect
to the schedule for clinical assessment in neuropsychiatry
(SCAN) [40]. In this study, the respondents’ answers to the
CIS-R were used to define ICD-10 diagnoses of depressive
episode (including mild, moderate and severe).
Procedure
Sixteen practices in South East and South West London
were recruited to participate in the study. The total practice
population was 142,648 patients; 2.1% (2938/142,648) were on
the QOF CHD registers. Thirty two per cent of people invited by
their GP to participate in the study agreed to contact from the
research team; of these 87.6% (803/917) consented to
involvement and were recruited, representing 28.2%
(803/2843) of those registered on the CHD registers of
participating practices. Those patients who consented to
participate were contacted by a researcher and the interview
schedule including the HADS-D, the PHQ-9 and the CIS-R
were administered face to face at their homes or GP practice.
The PHQ-9 and HADS-D were delivered blind to the results of
the diagnostic interview as the diagnostic categories were not
calculated until the analysis stage. Further details of the
method have been published elsewhere [30].
Statistical analyses
All data were analysed using STATA 11.2. For all
calculations, α was 0.05 and tests were two-tailed. A
concurrent analysis was made of PHQ-9 and HADS-D scales.
Convergent validity was assessed by Pearson product moment
correlation between the two scales, and internal consistency of
the scales was assessed using Cronbach’s alpha and item-
total correlations.
Criterion validity was evaluated by determining the sensitivity
and specificity for various cut-off scores on the PHQ-9 and
HADS and for the PHQ-9 categorical algorithm in comparison
to depressive episode as determined by CIS-R items (the
criterion standard). We also plotted Receiver Operating
Characteristic (ROC) curves for the scales (the true positive
rate, sensitivity, plotted against the false positive rate, 100-
Specificity) for all scale points to identify diagnostic superiority.
Each point on the ROC plot represents a sensitivity/ specificity
pair corresponding to a particular decision threshold. A test
with perfect discrimination (no overlap in the two distributions)
has a ROC plot that passes through the upper left corner
(100% sensitivity, 100% specificity). Therefore the closer the
ROC plot is to the upper left corner, the higher the test’s overall
accuracy. A global test was used for statistical comparison of
area under the curve (AUC). The AUCs were then compared
pairwise to assess diagnostic superiority. We used the Youden
index (sensitivity+specificity−1) to provide a single numerical
estimation of the overall diagnostic effectiveness and to
summarise the accuracy of the test instrument. This provides a
value that may range between 0 and 1, where 1 means that the
test is perfect.
As other researchers have advocated for depression
screening, particularly when a two-stage procedure may be
used with initial identification followed-up with more detailed
assessment [21,22], cut-off scores demonstrating maximal
sensitivity and specificity of ≥75% were examined.
Convergence of the scales’ severity bandings was also
compared relative to the CIS-R.
Results
Sample Characteristics
The cohort consisted of 803 patients, of which 65 (8.1%)
were currently diagnosed or being treated for depression. The
findings reported here include only those recruited patients not
recognised or treated for depression for whom all items of the
PHQ-9, HADS-D and cis-R-D were completed (n=730). The
sample was predominantly male (n=516; 71%), white (n=635,
87%), with a mean age of 71.2 years (S.D. = 10.5). Socio-
economic status was represented using the index of multiple
deprivation (IMD) scores for which higher scores indicate
Detecting Depression in Coronary Disease Patients
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greater deprivation in the area. The median IMD was 18.4, with
individual scores ranged from 1.7 to 61.6 (interquartile range
25.8). Patients in the cohort has been diagnosed with CHD for
a mean duration of 10.4 years (S.D. = 7.9), and 80% were
diagnosed with other comorbid medical conditions, most
commonly hypertension (55%) and diabetes (25%); two or
more comorbid medical conditions were recorded for 48% of
patients. Current chest pain was present in 44% of the sample
population, and 42% had documented history of myocardial
infarction.
Depression Measures
Of the recruited patients without previously identified or
treated depression, 32 (4.4%) met the diagnostic criteria for
ICD-10 depressive episode according to the CIS-R, (53 [6.6%]
when analysis included the entire cohort), and of these 11 (17
without exclusion of patients already recognised as depressed)
were identified as severely depressed. Mean scores on the
PHQ-9 and HADS-D were 4.5 (S.D. =5.4, range 0-27) and 3.1
(S.D. =3.5, range 0-19), respectively.
78 patients, 10.7%, were identified as depressed by HADS-D
≥8 (103 patients [13%] among the entire cohort), whilst 100
patients, 13.6%, scored ≥10 on the PHQ-9 (136 patients [17%]
when the analysis was unrestricted). The demographic and
depression status characteristics of the sample are shown in
Table 1.
Internal consistency, homogeneity and convergent
validity.  The internal consistency (measured within the entire
cohort) of both depression scales was high: Cronbach’s α for
the PHQ-9 was 0.85 (n=801) and for the HADS (D), 0.80
(n=799). This indicates that both scales exhibit acceptable
internal consistency with little likelihood of item redundancy.
Item total correlations were consistently satisfactory for each
item of each questionnaire: the Pearson Product moment
correlations ranged from 0.21 to 0.61 for the PHQ-9 and from
0.26 to 0.57 for the HADS-D. These values are all above the
threshold 0.2 and therefore indicate that all individual items
correlate with the scales from which they originate.
Assessment of convergent validity included participants who
had completed both questionnaires completely (n=797). The
Pearson’s correlation coefficient between HADS-D and PHQ-9
total scores was substantial r=0.71. For HADS-D and PHQ-9,
r2=0.64, that is HADS-D sum score accounted for 64% of the
variance in the PHQ-9 scores, providing good evidence of the
extent to which the scales measure the same construct.
Criterion Validity.  The operating characteristics of the
scales are shown in Table 2, calculated for the 730 participants
completing all instrument items and not previously identified as
depressed. At least three potential cut-off points are shown for
each instrument, calculated using HADS-D sum scores, PHQ-9
sum scores and the PHQ-9 categorical algorithm. Additional
tables provided as Supporting Information (Tables S1-S3)
show the results for all cut-off scores for both instruments.
Overall, the instruments had sensitivities of 53% to 94% and
specificities of 57% to 91% using standard cut-points and those
suggested by prior studies (Table 2).
Of the evaluated cut-points, PHQ-9 at ≥8 appeared to
provide the optimal test characteristics in this population:
although a similar proportion of cases of depression was
identified at a lower cut-point, the combination of test values
(sensitivity=94%; specificity=84%; Youden Index 0.78)
supports the selection of this cut-point. The difference in
performance between the cut-point routinely recommended
(≥10) and that identified in this analysis was relatively modest
for the PHQ-9; whilst for the HADS-D the standard cut-point of
≥8 provided a low sensitivity, 53%, with adequate specificity of
91%. The HADS-D at ≥5 demonstrated a sensitivity and
specificity values of 81% and 77% respectively, whilst for a
lower cut-point specificity fell below 75%.
PHQ-9 scoring by the categorical algorithm for major
depression provided sensitivity and specificity values of 59%
and 95%; whilst for ‘other depression’ respective values were
94% and 84%.
The AUCs of the PHQ-9, the PHQ-9 algorithm and the
HADS-D for detecting depressive episode were 0.95 (SE 0.01,
95% CI 0.92 - 0.97), 0.91 (SE 0.02, 95% CI 0.86 - 0.96) and
0.88 (SE 0.02, 95% CI 0.84 - 0.92) respectively (Figure 1).
Statistical comparison using the global test for the AUCs of the
PHQ algorithm, the PHQ and HADS-D over all possible cut-off
points was statistically significant (P<0.01). Pairwise statistical
comparison of the AUCs showed that differences between the
PHQ-9 and HADS-D sum scores (P<0.01) and between the
PHQ score and PHQ algorithm (P=0.03), were statistically
Table 1. Sample characteristics of the primary care coronary heart disease register patients.
 No depressive disorder (CIS-R) (n=698) Depressive disorder (CIS-R) (n=32) P value
Female 201 (28.8%) 13 (40.6%) 0.151
Age, years (mean, SD) 71.44 (10.44) 65.28 (10.81) 0.001
Married 454 (65.0%) 17 (54.8%) 0.245
Employed 128 (18.4%) 10 (32.3%) 0.053
Current chest pain 287 (41.1%) 27 (84.4%) <0.001
IMD score (mean, SD) 19.75 (13.96) 24.16 (13.25) 0.0803
PHQ-9 score (mean, SD) 3.60 (4.23) 14.84 (5.32) <0.001
PHQ categorical algorithm Other depression 82 (11.6%) 11 (34.4%) <0.001
 Major depression 33 (4.7%) 19 (59.4%)  
HADS-D score (mean, SD) 2.84 (2.99) 8.06 (3.44) <0.001
doi: 10.1371/journal.pone.0078493.t001
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significant, suggesting the PHQ-9 is diagnostically superior to
the other approaches for identifying depression episode.
Pairwise statistical comparison between the HADS and the
algorithm did not show a significant difference (P=0.18),
suggesting that neither is diagnostically superior to the other in
identifying depression.
PPV values for all the instruments tended to be low (10% to
28%), whilst the NPV values were very high (98% to 100%),
implying that there is a high probability that depression is
absent when the PHQ-9 test is negative, but that risk of false
positives is high when these measures are used with a primary
care CHD population.
The PHQ-9, using summed scoring and a cut-point of ≥8
appeared the best performing instrument for use with this
patient group.
Diagnostic accuracy analyses were also conducted without
excluding those patients already recognised or treated for
depression: the same PHQ-9 cut-point (≥8) was found to be
optimal, with similar sensitivity (94%) and specificity values
(82%), however (because of the higher prevalence), the PPV
value was 27% rather than 21%.
Severity bandings.  As noted, CIS-R algorithms enable
ICD-10 depressive episode to be categorised by severity, and
similarly the PHQ-9 and HADS-D scores may be interpreted
according to severity cut-offs. Table 3 shows the score
distributions for these measures, revealing the lack of
concurrence between the severity ranges; the PHQ-9 ‘mild
depression’ category is particularly problematic as the
recommended score range (5-9) falls below this measure’s
standard cut-point for the presence of depression (≥10).
Although scores on both the PHQ-9 and HADS-D assigned
greater numbers of people to mild and moderate depression
than the CIS-R standard, this tendency was more pronounced
for the PHQ-9 which categorised around four times as many
participants in this way than the CIS-R, whereas around mild
and moderate depression was indicated likely in around three
times as many patients by HADS-D score compared to the
reference standard.
Discussion
The main aim of this study was to determine the
performance characteristics of two commonly used self-report
case identification instruments, the PHQ-9 and the HADS-D,
for depression relative to a referent diagnostic standard in
primary care patients with CHD. The findings reveal high levels
of internal consistency and substantial intercorrelations
between both instruments which is indicative of their construct
validity.
Criterion validity for the PHQ-9 using both summed and
categorical scoring was good. At the standard recommended
cut-point of ≥10, findings within this primary care CHD sample
were near identical to those derived from meta-analysis of six
studies of this instrument’s use with patients recruited on the
basis of their chronic medical conditions [23]. Whist the current
study indicated sensitivity as 84% and specificity as 90%, the
corresponding results of the meta-analysis were 84% and 88%.
An improvement in PHQ-9 performance was evident upon
application of a lower cut-point (of ≥8), resulting in increased
sensitivity with only modest reduction in specificity. The PHQ-9
scored by diagnostic algorithm methods for major depression
performed less well, though results were markedly better than
in other studies with CHD patients [22,26], and were generally
similar to those obtained from meta-analyses of PHQ-9
accuracy among patients in primary care and medical settings
[41].
The performance of the HADS-D at the standard cut-point (of
≥8) was weaker, with a large proportion of true cases likely to
Table 2. Depressive disorder: PHQ-9 algorithm, PHQ-9 and HADS (D) operating characteristics.
 Sensitivity (95% CI)Specificity (95% CI)
Positive
Likelihood Ratio
Negative
Likelihood ratio Youden Index
Positive
Predictive Value
(%)
Negative
Predictive Value
(%)
PHQ (n=730)        
Cut-off point ≥7 93.8 (79.2, 99.2) 80.7 (77.5, 83.5) 4.8 0.1 0.74 18.2 99.7
Cut-off point ≥8 93.8 (79.2, 99.2) 83.8 (80.9, 86.5) 5.8 0.1 0.78 21.0 99.7
Cut-off point ≥9 87.5 (71.0, 96.5) 86.7 (83.9, 89.1) 6.6 0.1 0.74 23.1 99.3
Cut-off point ≥10 84.4 (67.2, 94.7) 89.8 (87.3, 92.0) 8.3 0.2 0.74 27.6 99.2
PHQ-9 Categorical algorithm
(n=730)        
Major depression 59.4 (40.6, 76.3) 95.3 (93.4, 96.7) 12.6 0.4 0.547 36.5 98.1
Other depression 93.8 (79.2, 99.2) 83.5 (80.6, 86.2) 5.7 0.1 0.773 20.7 99.7
HADS(n=730)        
Cut-off point ≥3 100.0 (79.2, 99.2) 57.0 (53.3, 60.7) 2.3 0.0 0.57 9.6 100.0
Cut-off point ≥4 93.8 (63.6, 92.8) 67.8 (64.2, 71.2) 2.9 0.1 0.62 11.8 99.6
Cut-off point ≥5 81.3 (46.8, 81.4) 76.7 (73.3, 79.7) 3.5 0.2 0.58 13.8 98.9
Cut-off point ≥6 65.6 (40.6, 76.3) 83.1 (80.1, 85.8) 3.9 0.4 0.49 15.1 98.1
Cut-off point ≥7 59.4 (34.7, 70.9) 88.3 (85.6, 90.5) 5.1 0.5 0.48 18.8 97.9
Cut-off point ≥8 53.1 (26.4, 62.3) 91.4 (89.1, 93.4) 6.2 0.5 0.45 22.1 97.7
doi: 10.1371/journal.pone.0078493.t002
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be missed (sensitivity=53% specificity=91%). This result is
similar to the findings from an Australian sample of patients 3-
months following hospital discharge for CHD related events/
procedures where a sensitivity of 46% and specificity of 92%
were identified using this cut-point [22]. A meta-analysis of 29
studies using the HADS-D at standard cut-point provided a
higher sensitivity 75%, with specificity 81% [22]. In the current
study satisfactory performance of the HADS-D scale required a
cut-point of ≥5, and though adequate, the resulting test
characteristics were considerably weaker than the PHQ-9.
Other studies have identified the diagnostic superiority of the
PHQ-9 over the HADS-D among patients with medical co-
morbidities [24]. However, part of the reason for this is likely to
be because many of these studies have used DSM-IV-based
diagnostic measures as the criterion standard, and the PHQ-9
was developed to match DSM-IV criteria on an item-by-item
basis, whereas the HADS-D was developed to assess
depression in medically ill patients and its items are centred on
loss of interest and pleasure with somatic features excluded
from measurement. Hence, findings of high criterion validity for
the PHQ-9 in relation to DSM-IV major depression relate in part
to its content validity. A strength of the current study is that it
differs from the majority of other evaluations of the PHQ-9 in
that the criterion standard is based on ICD-10 criteria, so
Figure 1.  Receiver operating characteristic curves for PHQ-9, HADS-D, and PHQ-9 categorical algorithm; CIS-R was the
criterion standard.  
doi: 10.1371/journal.pone.0078493.g001
Table 3. Distribution of participants by CIS-R, PHQ-9 and HADS-D severity ratings.
CIS-R n (%) PHQ-9 n (%) HADS-D n (%)
No depression 702 (95.5) No depression 196 (26.7) 634 (86.4) No depression 653 (89.3)
  Minimal depression (1-4) 296 (40.3)    
  Mild depression (5-9) 142 (19.4)    
Mild depression 13 (1.8) 33 (4.5) Moderate depression (10-14) 61 (8.3) 100 (13.6) Possible/ mild depression (8-10) 50 (6.8) 103 (10.6)
Moderate depression 9 (1.2)  Moderately severe depression (15-19) 27 (3.7)  Probable depression, moderate (≥11-15) 24 (3.3)  
Severe depression 11 (1.5)  Severe depression (≥20) 12 (1.6)  Probable depression, severe (>15) 4 (0.6)  
doi: 10.1371/journal.pone.0078493.t003
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avoiding this element of circularity which may occur in
psychometric evaluations of the PHQ-9 in relation to the
diagnostic measure on which it is based.
Another important strength of this study is its setting in a
primary care population which is where most people with CHD
are provided with ongoing monitoring and support, and hence
the setting in which the opportunity and imperative for detecting
depression is most clear.
In line with expert recommendations we excluded from
diagnostic accuracy analyses those patients that were either
recognised or treated for depression at the time of the study.
This approach is designed to ensure the avoidance of
spectrum bias and associated overestimation of the accuracy
of test measures, and in particular elevated values for the
positive predictive value of the index tests. Although there was
relatively little change in the sensitivity and specificity of the
index measures associated with this procedure, the changed
prevalence of depression in the sample population resulted in
positive predictive values that were markedly reduced (at the
optimal cut-points: PHQ-9 21% v 27%; PHQ-9 algorithm 37% v
46% ; HADS-D 14% v 20%).
The discrepant findings in relation to severity bandings
between the PHQ-9 and HADS-D have been identified in
previous primary care studies [20,29]. In part this may relate to
the severity categories recommended by the PHQ-9’s authors:
problematically the ‘mild depression’ banding does not include
sufficient symptoms of adequate severity to meet major
depression criteria of any severity, and falls below the standard
cut-point for depressive episode/major depression; whilst the
additional sub-division of ‘moderately severe’ depression does
not link to diagnostic manuals and clinical guidelines.
Interestingly, this categorisation of the PHQ-9 score is not
adopted by the McArthur Foundation [42] initiative on
depression and primary care (which notes PHQ-9 scores of
10-14 as indicative mild depression), nor was it used in a
recent large-scale evaluation of the PHQ-9 in primary care [43].
Other studies have identified higher rates of depression
among patients with CHD (and other chronic medical
conditions) than our study: Rudisch and Nemeroff [44] reported
prevalence rates for depression in CHD ranging from 17% to
27%, whilst post-MI prevalence rates have been noted to range
between 16% and 27% [45]. It is possible that the pooled
prevalence estimate of 20% reported for depression following
MI as identified by diagnostic measure [45] may be affected by
inaccuracies in determining depression rates in the largest of
the studies included [46]. A lower prevalence of depression has
been identified in community-based studies using a nationally
representative population sample rather than one drawn from
outpatients or people recently hospitalised: a study based on
National Health Interview Survey data of 30 801 adults found
the 12-month prevalence of major depression to be 9.3% in
individuals with CHD as compared with 4.8% in those with no
comorbid medical illness [47]. In general, a two- to three- fold
increase in depression prevalence compared to the general
population is observed, and in this study the prevalence of 7%
indicated from CIS-R results may be compared with the British
household population rate identified using the same measure
of 2% for depressive episode [48].
A possible limitation of this study is that recruitment of the
sample was limited to general practices based in South
London, and only 28% of eligible patients participated in this
study. This low participation rate relates in part to the
recruitment strategy demanded by UK research ethics
committees for primary care research which requires GPs to
gain initial patient consent prior to researchers contacting
patients to obtain fully informed consent. Comparison of the
characteristics of the study sample with relevant data for
England indicates generalizability. The study participants were
predominantly (70%) male, whilst data for England indicate that
62% of CHD cases are male; the mean age of participants was
71 years, and data for England indicates that 93% of people
with CHD are aged over 55 years and 79% aged over 65 years
[49]. 2.1% of patients within the 16 included practices were on
the QOF CHD registers, which compares with 2.2% for the
London Strategic Health Authority area, 2.9% for the wider
South Central area, and 3.5% for England (http://
www.gpcontract.co.uk/child/ENG/CHD%201/11). The number
of practices involved (n=16) together with the ethnic and socio-
economic diversity provided by their differing geographical
settings provide some indication that the participants reflect the
spectrum of patients who would normally be seen in clinical
practice, and that the results will generalise to the wider
primary care population.
Conclusions
Despite these limitations, this study provides robust findings
based on a large scale primary care population of people with
CHD, showing the psychometric properties of commonly used
depression case finding measures. The results indicate the
superiority of the PHQ-9 for depression case identification in
this patient group, and are largely consistent with the findings
of reviews of depression identification tool performance among
people with chronic physical health problems in showing
acceptable diagnostic properties for this instrument. To our
knowledge, this is the first study to compare the PHQ-9 and
HADS-D against a diagnostic standard among patients with
CHD in primary care; other similar studies have been based on
patients from cardiology outpatient clinics, or following cardiac
surgery, or post-myocardial infarction. Among this primary care
CHD population the sensitivity (94%) and specificity (84%) of
the PHQ-9 using a cut-point of at ≥8 were found to be better
than the median values identified in a systematic review of
screening instruments for depression in cardiovascular care
(84% and 79% respectively) [25]. However, if the low
depression prevalence (6.7% overall, but 4.4% not otherwise
recognised) found in our study is accurate, this indicates that
only around 20% of PHQ-9 newly identified cases are true
cases; whilst if depression prevalence in this population were
20% [45], the true positive proportion would be around 60% for
this instrument. With a depression prevalence of 12% (based
on re-examination of ENRICHD data combined with other
studies of post-MI patients), around 40% of identified cases
would be true positives.
We know that depression is predictive of increased disability
and raised mortality in people with CHD and that standard
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pharmacological and psychosocial interventions are effective in
treating such co-morbid depression – not only for mental health
outcomes, but emerging evidence indicates for cardiovascular
outcomes and survival rates too [50]. Among CHD patients, the
deleterious effects of comorbid depression coupled with its
under-recognition indicate that accurate detection must remain
a clinical priority. The findings of this study extend our
knowledge of the characteristics of case identification
measures to assist in this important area, and provide useful
guidance on appropriate tools and optimal cut-off scores for
use in primary care. However, the current study is not able to
shed light on whether using case identification measures
among this at-risk population is associated with increased
delivery of appropriate clinical interventions to screen-positive
patients or of real-world clinical outcome benefits. Recent
retrospective examination of a large database of primary care
patients in Scotland [51] indicated that screening those with
either CHD or diabetes was associated a significant but small
increase in new diagnoses of depression and a new course of
antidepressant in the month after screening. However, these
authors caution that the resource implications of such
screening approaches may not be justified by the modest
improvements beyond standard care. Although we have found
the PHQ-9 to possess adequate diagnostic accuracy for this
patient group, this finding is insufficient to determine whether
using this instrument will result in improvement in patient
management or outcomes.
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